<DOC>
	<DOC>NCT01417754</DOC>
	<brief_summary>To investigate if there are detectable changes in volume and circulation in breasts of healthy volunteers using toremifene 20 mg in luteal phase of the menstruation cycle versus nonmedicated cycle.</brief_summary>
	<brief_title>Changes in Breast 3D Ultrasound Measurements Using Toremifene</brief_title>
	<detailed_description>20 women were participated to this trial.</detailed_description>
	<mesh_term>Toremifene</mesh_term>
	<criteria>age 2545 healthy person regular menstrual cycles safe contraception(for example sterilization or condom) gynecological or other type of cancer hormonal contraception pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>toremifene</keyword>
</DOC>